{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:01:28Z","timestamp":1784368888638,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.autrev.2021.103030","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T21:00:14Z","timestamp":1640725214000},"page":"103030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathogenesis-based new perspectives of management of ANCA-associated vasculitis"],"prefix":"10.1016","volume":"21","author":[{"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"6342","key":"10.1016\/j.autrev.2021.103030_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1445-5994.1984.tb03769.x","article-title":"Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody","volume":"14","author":"Hall","year":"1984","journal-title":"Aust N Z J Med"},{"issue":"8426","key":"10.1016\/j.autrev.2021.103030_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet."},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2021.103030_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04355.x","article-title":"Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?","volume":"164","author":"Kallenberg","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2021.103030_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102911","article-title":"Monocytes and macrophages in ANCA-associated vasculitis","volume":"20","author":"Vegting","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0035","doi-asserted-by":"crossref","first-page":"102495","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical associations of renal involvement in ANCA-associated vasculitis","volume":"19","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103030_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfn354","article-title":"Renal vasculitis in Japan and the UK - are there differences in epidemiology and clinical phenotype?","volume":"23","author":"Watts","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.autrev.2021.103030_bb0045","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2021.103030_bb0050","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1445-5994.2006.01297.x","article-title":"Wegener\u2019s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient","volume":"37","author":"O\u2019Donnell","year":"2007","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103030_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated Vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2021.103030_bb0075","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.40034","article-title":"Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody\u2013associated vasculitis","volume":"69","author":"Merkel","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/jcm8020266","article-title":"Genetic variants in antineutrophil cytoplasmic antibdy-associated vasculitis: a Bayesian approach and systematic review","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.autrev.2021.103030_bb0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","article-title":"The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis","volume":"12","author":"G\u00f3mez-Puerta","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"27","key":"10.1016\/j.autrev.2021.103030_bb0095","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2021.103030_bb0100","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0105","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41467-019-11255-0","article-title":"A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity","volume":"10","author":"Ooi","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2016.45","article-title":"Innate immunity and inflammation","volume":"14","author":"Xiao","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2249.2000.01205.x","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro","volume":"120","author":"Hellmich","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1361.041","article-title":"Activation, apoptosis, and clearance of neutrophils in Wegener\u2019s granulomatosis","volume":"1051","author":"van Rossum","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2021.103030_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2010.138024","article-title":"Pathogenesis of ANCA-associated vasculitides","volume":"70","author":"Kallenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2021.103030_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097843","article-title":"Coagulation and fibrinolysis index profile in patients with ANCA-associated vasculitis","volume":"9","author":"Ma","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.autrev.2021.103030_bb0135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ekir.2019.12.018","article-title":"Narrative review of hypercoagulability in small-vessel vasculitis","volume":"5","author":"Claudel","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2012.101","article-title":"Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis","volume":"82","author":"Paust","year":"2012","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0145","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/rheumatology\/kez089","article-title":"The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis","volume":"58","author":"Hattanda","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0150","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2021.103030_bb0160","first-page":"139","article-title":"Macrophages in vascular inflammation.- From atherosclerosis to vasculitis","volume":"15","author":"Shirai","year":"2021","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","article-title":"Overview of the pathogenesis of ANCA-associated vasculitis","volume":"1","author":"Xiao","year":"2016","journal-title":"Kidney Dis (Basel)"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2923","article-title":"T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?","volume":"12","author":"Wilde","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.103030_bb0175","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.semnephrol.2017.05.016","article-title":"ANCA-associated vasculitis: pathogenesis, models, and preclinical testing","volume":"37","author":"Hutton","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fimmu.2014.00432","article-title":"T cell\u2013macrophage interactions and granuloma formation in vasculitis","volume":"5","author":"Hilhorst","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.autrev.2018.08.006","article-title":"Th17 cells in renal inflammation and autoimmunity","volume":"18","author":"Dolff","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ckj\/sfz029","article-title":"T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach","volume":"12","author":"Martinez Valenzuela","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2021.103030_bb0195","article-title":"NKG2D signaling certifies effector CD8 T cells for memory formation","volume":"7(1):48","author":"Perez","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener\u2019s granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0205","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener\u2019s granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103030_bb0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2014.00504","article-title":"T cells in vascular inflammatory diseases","volume":"5","author":"Lintermans","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000072987","article-title":"The Th1 and Th2 paradigm in ANCA-associated vasculitis","volume":"26","author":"JSF","year":"2003","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2249.2004.02566.x","article-title":"Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener\u2019s granulomatosis: a possible pathogenic role for the IgG4 subclass","volume":"138","author":"Holland","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/08916930400022673","article-title":"Antineutrophil cytoplasmic antibodies (ANCA)","volume":"38","author":"Radice","year":"2005","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213215","article-title":"Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity","volume":"14","author":"Lardinois","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2003.09.013","article-title":"Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies","volume":"65","author":"Reumaux","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/ar392","article-title":"Staphylococcus aureus and Wegener\u2019s granulomatosis","volume":"4","author":"Popa","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2021.103030_bb0250","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR- (105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0255","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1681\/ASN.V1371977","article-title":"ANCA are pathogenic-yes they are!","volume":"13","author":"Falk","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fimmu.2020.00525","article-title":"Animal models of ANCA associated vasculitis","volume":"11","author":"Shochet","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0265","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103030_bb0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2249.1992.tb07934.x","article-title":"Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies","volume":"90","author":"Keogan","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0275","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1182\/blood-2008-12-192617","article-title":"Antimyeloperoxidase antibodies rapidly induce alpha-4-integrin-dependent glomerular neutrophil adhesion","volume":"113","author":"Kuligowski","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0280","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M","article-title":"Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion","volume":"43","author":"Radford","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2021.103030_bb0285","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1681\/ASN.V125932","article-title":"Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1","volume":"12","author":"Taekema-Roelvink","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0290","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103030_bb0295","first-page":"1695","article-title":"Autoantibodies to myeloperoxidase aggravate mild anti-glomerular- basement-membrane-mediated glomerular injury in the rat","volume":"149","author":"Heeringa","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.103030_bb0300","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.1995.58","article-title":"Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies","volume":"47","author":"Kobayashi","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.103030_bb0305","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.177.4.905","article-title":"Antimyeloperoxidase-associated proliferative glo-merulonephritis: an animal model","volume":"177","author":"Brouwer","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103030_bb0310","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/1529-0131(200107)44:7<1698::AID-ART294>3.0.CO;2-J","article-title":"Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro","volume":"44","author":"Weidner","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103030_bb0315","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ajpath.2017.05.003","article-title":"Monocytes promote crescent formation in anti-myeloperoxidase antibody-induced glomerulonephritis","volume":"187","author":"Rousselle","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.103030_bb0320","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis \u2014 a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2021.103030_bb0325","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/rheumatology\/ken321","article-title":"Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis","volume":"47","author":"Gao","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2021.103030_bb0330","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrneph.2012.108","article-title":"Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0335","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0340","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","article-title":"Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs","volume":"45","author":"Schlieben","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0345","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO, 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"RAVE-ITN research group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2021.103030_bb0355","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0360","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1681\/ASN.2006020108","article-title":"Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis","volume":"17","author":"Ruth","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000503969","article-title":"The presence of renal IgG deposits in necrotizing crescentic glomerulonephritis associated with ANCA is not related to worse renal clinical outcomes","volume":"6","author":"Dudreuilh","year":"2020","journal-title":"Kidney Dis"},{"key":"10.1016\/j.autrev.2021.103030_bb0370","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00005792-199411000-00005","article-title":"Wegener\u2019s granulomatosis: studies in eighteen patients and a review of the literature","volume":"73","author":"Fauci","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2021.103030_bb0375","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1159\/000096960","article-title":"Mechanisms of vasculitis: how Pauci-immune is ANCA-associated renal vasculitis?","volume":"105","author":"van Paassen","year":"2007","journal-title":"Nephron Exp Nephrol"},{"issue":"14","key":"10.1016\/j.autrev.2021.103030_bb0380","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.molimm.2011.04.024","article-title":"Complement activation by (auto-) antibodies","volume":"48","author":"Daha","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0385","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"Sorman","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0390","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0395","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0400","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.103030_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038317","article-title":"p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation","volume":"7","author":"Hao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.103030_bb0410","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2215\/CJN.02790313","article-title":"Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN","volume":"8","author":"Gou","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.autrev.2021.103030_bb0420","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.41011","article-title":"Measuring circulating complement activation products in myeloperoxidase- and proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218272","article-title":"Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation","volume":"14","author":"Ohlsson","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0430","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0435","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2013.08.006","article-title":"Complement in ANCA-associated vasculitis","volume":"33","author":"Jennette","year":"2013","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0440","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nephro.2019.04.001","article-title":"Complement inhibition in ANCA vasculitis","volume":"15","author":"Jayne","year":"2019","journal-title":"Nephrol Ther"},{"issue":"11","key":"10.1016\/j.autrev.2021.103030_bb0445","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.biocel.2009.04.005","article-title":"Complement component 5a (C5a)","volume":"41","author":"Manthey","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"10.1016\/j.autrev.2021.103030_bb0450","first-page":"2741","article-title":"TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.Europ","volume":"41","author":"Raby","year":"2011","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0455","doi-asserted-by":"crossref","DOI":"10.1186\/ar4604","article-title":"The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation","volume":"16","author":"Hao","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.103030_bb0460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ki.2012.371","article-title":"Complement is crucial in the pathogenesis of ANCA-associated vasculitis","volume":"83","author":"Kallenberg","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.103030_bb0465","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2010-05-283564","article-title":"Complement alternative pathway acts as a positive feedback amplification of neutrophil activation","volume":"117","author":"Camous","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103030_bb0470","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2016.11.013","article-title":"The functional activities of complement factor H are impaired in patients with ANCA-positive vasculitis","volume":"175","author":"Chen","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103030_bb0475","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fimmu.2018.00559","article-title":"Complement factor H inhibits anti-neutrophil cytoplasmic autoantibody-induced neutrophil activation by interacting with neutrophils","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2021.103030_bb0480","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cei.13051","article-title":"Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"191","author":"Cheng","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2021.103030_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195680","article-title":"Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Deshayes","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0490","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40620-017-0445-3","article-title":"Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome","volume":"31","author":"Crnogorac","year":"2019","journal-title":"J Nephrol"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158871","article-title":"Low serum complement C3 levels at diagnosis of renal ANCA-associated vasculitis is associated with poor prognosis","volume":"11","author":"Augusto","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2021.103030_bb0500","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10157-018-1634-7","article-title":"Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis","volume":"23","author":"Choi","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"10.1016\/j.autrev.2021.103030_bb0505","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s10067-019-04636-9","article-title":"Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study","volume":"38","author":"Garc\u00eda","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2021.103030_bb0510","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0515","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0520","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2021.103030_bb0525","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103030_bb0530","article-title":"Avacopan: First Approval","author":"Lee","year":"2021","journal-title":"Drugs."},{"issue":"19","key":"10.1016\/j.autrev.2021.103030_bb0535","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.autrev.2021.103030_bb0540","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2021.103030_bb0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"issue":"32","key":"10.1016\/j.autrev.2021.103030_bb0550","doi-asserted-by":"crossref","first-page":"52072","DOI":"10.18632\/oncotarget.18120","article-title":"The \u201c4 plus 2\u201d rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: a 10 years observation study","volume":"8","author":"Roccatello","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.autrev.2021.103030_bb0555","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.autrev.2017.07.015","article-title":"\u201cHow I treat\u201d autoimmune diseases: state of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis","volume":"16","author":"Roccatello","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103030_bb0560","series-title":"Treating Extremely Compromised Patients with ANCA-Associated Vasculitis with the Intensified B Cell Depletion Induction Therapy: A Controlled Study Submitted","author":"Roccatello","year":"2021"},{"issue":"6","key":"10.1016\/j.autrev.2021.103030_bb0565","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.kint.2021.08.025","article-title":"Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis","volume":"100","author":"Gulati","year":"2021","journal-title":"Kidney Int"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:25:04Z","timestamp":1761600304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1568997221003128"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.103030","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis-based new perspectives of management of ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.103030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103030"}}